Science Explorer Back to mapMap
Discussion
Researcher · Royal Brompton Hospital · United Kingdom

Michael R. Loebinger

Michael R. Loebinger publishes mostly in Pulmonary and Respiratory Medicine, Epidemiology and Infectious Diseases, on topics such as Cystic Fibrosis Research Advances, Neonatal Respiratory Health Research and Mycobacterium research and diagnosis.

ORCID 0000-0002-5965-9913 OpenAlex
World rank
#24,871
of 7,710,434 ranked researchers
Rank in United Kingdom
#1,830
of 367,258
Works
354
Citations
14k
Citations per work
40.4
h-index
61
i10-index 130Top 1.3% in Pulmonary and Respiratory Medicine
Michael R. Loebinger

What does Michael R. Loebinger research?

Michael R. Loebinger's work is mostly in Medicine (70%), Health Professions (5%), Biochemistry, Genetics and Molecular Biology (3%).

Health Sciences: 265 works · 74.8% of their workMedicine: 247 works · 69.9% of their workPulmonary and Respiratory Medicine: 173 works · 48.8% of their workEpidemiology: 42 works · 11.9% of their workInfectious Diseases: 21 works · 6.0% of their workSurgery: 11 works · 3.2% of their workHealth Professions: 17 works · 4.9% of their workEmergency Medical Services: 17 works · 4.9% of their workEverything else: 80 works · 22.6% of their workLife Sciences: 9 works · 2.6% of their workBiochemistry, Genetics and Molecular Biology: 9 works · 2.6% of their workGenetics: 9 works · 2.6% of their workTHEIR WORKMichael R.Loebinger354works
Life Sciences3%Health Sciences75%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine24769.9%
    2. Health Professions174.9%
  2. Everything else8022.6%
    1. Biochemistry, Genetics and Molecular Biology92.6%
  1. 1Pulmonary and Respiratory Medicine49% of their works
  2. 2Epidemiology12% of their works
  3. 3Infectious Diseases6% of their works
  4. 4Emergency Medical Services5% of their works
  5. 5Surgery3% of their works
  6. 6Genetics3% of their works

Research topics

Which keywords describe Michael R. Loebinger's research?

The keywords of their largest research topics: Cystic Fibrosis, CFTR, Pulmonary Infections, Diagnosis, Epidemiology, Treatment, Bronchopulmonary Dysplasia and Preterm Infants.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.

All 20 words, with their numbers
  1. Cystic Fibrosis2952 topics
  2. CFTR2271 topic
  3. Pulmonary Infections2271 topic
  4. Diagnosis1813 topics
  5. Epidemiology1503 topics
  6. Treatment1162 topics
  7. Bronchopulmonary Dysplasia951 topic
  8. Preterm Infants951 topic
  9. Mycobacterium avium681 topic
  10. Nontuberculous Mycobacteria681 topic
  11. COPD651 topic
  12. spirometry651 topic
  13. Airway Stenosis551 topic
  14. Tracheostomy551 topic
  15. Child Care501 topic
  16. Infection Control Measures501 topic
  17. Mycobacterium tuberculosis481 topic
  18. Tuberculosis481 topic
  19. Human Metapneumovirus341 topic
  20. Respiratory Syncytial Virus341 topic

Where does Michael R. Loebinger work?

Michael R. Loebinger's main affiliation in the publication record is Royal Brompton Hospital, United Kingdom.

How many publications and citations does Michael R. Loebinger have?

OpenAlex counts 354 works and 14,294 citations for Michael R. Loebinger, an h-index of 61, ranking #24,871 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Other researchers named Michael R. Loebinger

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Michael R. Loebinger. Posts are plain text and can be reported.